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Deregulation of the circadian clock constitutes a significant factor in tumorigenesis: a clockwork
cancer. Part I: clocks and clocking machinery
Kristin Uth and Roger Sleigh*
Centre for Molecular and Cellular Biosensor Research (CMCBR), Abertay University, Dundee, Scotland, UK
(Received 20 March 2014; accepted 11 April 2014)
Many physiological processes occur in a rhythmic fashion, consistent with a 24-h cycle. The central timing of the day/night
rhythm is set by a master clock, located in the suprachiasmatic nucleus (a tiny region in the hypothalamus), but peripheral
clocks exist in different tissues, adjustable by cues other than light (temperature, food, hormone stimulation, etc.),
functioning autonomously to the master clock. Presence of unrepaired DNA damage may adjust the circadian clock so that
the phase in which checking for damage and DNA repair normally occurs is advanced or extended. The expression of
many of the genes coding for proteins functioning in DNA damage-associated response pathways and DNA repair is
directly or indirectly regulated by the core clock proteins. Setting up the normal rhythm of the circadian cycle also
involves oscillating changes in the chromatin structure, allowing differential activation of various chromatin domains
within the 24-h cycle.
Keywords: circadian clock; regulation; cell cycle; DNA repair; carcinogenesis
Abbreviations
BER base excision repair
Cry cryptochrome
ESC embryonic stem cells
HMG high-mobility group
NER nucleotide excision repair
Per period
SCN suprachiasmatic nucleus
Circadian clocks and clock resetting
Many physiological processes follow a circadian pattern,
that is, they occur at specific times in the day/night cycle,
and/or their amplitude may vary rhythmically (oscillate)
within a cycle close to 24 hours. Such processes include
the sleepwakefulness cycle, the release of hormones, the
functioning of the cardiovascular, nervous, digestive and
waste disposal systems and others. The core circadian
clock machinery exists in every eukaryotic cell (and even
some prokaryotes  e.g. Cyanobacteria.[1]), but the over-
all regulation and coordination is carried out at a central
level (master clock  in the suprachiasmatic nucleus
(SCN) in the hypothalamus) and several autonomous lev-
els (peripheral clocks  in the heart, the lungs, the gut,
and other locations).
The circadian clock is adjustable (entrainable) by
exogenous (e.g. light, temperature, food, etc.) or endoge-
nous (e.g. hormone release) cues (triggers). Among
external clock-adjusting cues, light (daylight as well as
artificial) is prominent, as the master clock in the SCN is
predominantly entrainable by light. The signal is picked
up by the photoreceptors in the retina and sent to SCN via
the retinohypothalamic tract. This means that presence of
light must be registered by the visual perception to entrain
the master clock in the SCN. Illuminance as low as 34-
fold above basal may be sufficient for adjustment of the
SCN clock.[2] The entrainment of peripheral clocks is
typically dependent on stimuli other than light  amongst
them being changes in ambient temperature, food avail-
ability and noise levels. The circadian clock is self-sus-
tained, that is, in the absence of external cues (e.g.
constant darkness), the 24-h circadian rhythm set by the
internal clocks are preserved, at least for some time after
the entraining cues have been withdrawn (unless some of
the major molecules involved in circadian rhythm regula-
tion are missing or altered, in which case the cycle may
become shorter or longer). Typically, provision of the
missing cue/s adjusts the clock back to the 24-h schedule.
The circadian rhythms are cell-autonomous, that is,
they are not functions of cell populations only (e.g.
tissues, organs and organisms), but are faithfully main-
tained at single-cell level for some time after the external
cues have been removed.[3] In cells maintained for a long
time in in vitro culture, however, the circadian rhythms
may be lost or reset by exogenous cues (e.g. different tem-
perature, different O2 and CO2 levels, specific
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components of the nutrient medium, frequent medium
exchange, etc.).[4] Immortalized cell lines may need addi-
tional cues (e.g. from the nutrient medium) to maintain
their rhythmicity in vitro.[4,5]
In an environment deprived of a major entrainment
cue (e.g. insufficient light during the day) or environment
providing atypical cues (e.g. light at night), circadian
rhythms may be seriously disrupted in vivo, especially
when the disrupting factor(s) are chronically present or
when they are frequently but irregularly present. It is
known that light pollution may significantly affect the
physiology and behaviour of animals  for example, the
population density and swimming depth in fish; the post-
hatching behaviour of marine turtles; and the mating
behaviour in birds.[69] In humans, chronic insomnia at
night, sleep fragmentation and/or excessive daytime
sleepiness commonly occurs in medical personnel doing
frequent and/or rotating night shifts and in aircrew mem-
bers doing frequent long-haul flights crossing several time
zones. Sometimes, the consequences of disruption of cir-
cadian rhythms may be significantly more severe (e.g.
proneness to accidents because of episodes of microsleep
during the typical ‘activity phase’ (independent of sleep
deprivation); predisposition to multifactorial diseases and
conditions; poorer outcomes when the disease has already
developed, and others.
Core machinery of eukaryotic circadian clock
The core machinery of the circadian clock in eukaryotic
cells consists of several proteins forming a feedback loop,
which is regulated not only at the transcription level, but
also by post-translation modifications.[1012] The exact
composition of the set of clock-controlled genes con-
trolled may vary between different tissues, although the
total percentage is on the average 5%10%.[13] The pro-
moters of the clock-regulated genes are usually GC-rich.
[14] Core clock proteins activate their target proteins by
binding to specific DNA sites in their regulatory regions
(usually, E-boxes  with the consensus sequence
CAYGTG, where Y ¼ pyrimidine and D-boxes, with con-
sensus sequence RT(G/T)AYGTAAY, where R ¼ purine.
[15] Other regulatory elements overrepresented in pro-
moters of clock-controlled genes are sites for binding
non-histone proteins (e.g. high-mobility group (HMG)
type); the pro-proliferative proteins E2F and c-Myc;
STAT1 (member of the Jak-Stat signalling pathway); and
others.[14] Many of these proteins also exhibit a circadian
pattern of expression and/or are directly regulated by the
core clock machinery.
The mammalian proteins Clock, Bmal1 (Arntl1) and
Npas2 (the latter is present in the SCN only) are positive
regulators of the feedback loop. A heterodimer made of
Clock and Bmal1 (or Npas2) binds to and activates a set
of light-inducible genes specific to the tissue. The core
negative regulators of the circadian feedback loop are the
cryptochrome (Cry) proteins (from ‘cryptochrome’) Cry1
and Cry2 and period (Per) proteins (from ‘period’) Per1,
Per2 and Per3. These proteins have light-dependent as
well as light-independent functions [16] and their expres-
sion is activated by the binding of the Clock-Bmal1 heter-
odimer to E-box sequences in their promoters. Per and
Cry proteins form a complex that suppresses their own
transcription, as well as the expression of Clock and
Bmal1, thus closing the feedback loop.[17,18]
Besides the core circadian clock machinery, there are
also other proteins functioning in the regulation of the
diurnal rhythm in higher eukaryotes  e.g. Tim1 (Time-
less), Dec1 and Dec2, and others.[19,20]
Clockwork regulation of the cell cycle and the role of
persistence of unrepaired DNA damage for adjustment
of the circadian clock
Cell division normally follows a circadian pattern in
eukaryotic organisms. For example, the rates of prolifera-
tion of the epithelial cells in human rectal crypts are
higher at night and lower during the day.[21] The differ-
entiation of the epidermal progenitor cells in the upper
layers of the skin is dependent on circadian rhythms.[22]
The haematopoietic cell niche is also regulated in a circa-
dian fashion with regard to production of blood cells, the
targeting of cells at different stages of maturation to dif-
ferent topological and functional locations, and the
destruction of aged cells.[23,24] For a while, it was
believed that the rhythmic control of cell cycle concerned
mainly tissues with rapid turnover. Recently, however, it
was reported that even cells that are relatively rarely
replaced, such as adult stem cells, may proliferate in
rhythmic fashion. In hair follicles from adult mice, the
population of stem cells was found to contain discrete
stem cell populations that were in the opposite phases of
the clock and differentially sensitive to clock-adjusting
triggers.[25] The neural precursors in the subgranular
zone of adult hypocampus divide slowly but rhythmically,
with the entry and exit of the cell cycle controlled by
Bmal1 and Per2.[26] The proliferation and the differentia-
tion of mouse oligodendrocyte precursor cells was found
to occur in separate timepoints in the activity/rest cycle 
during sleep and wakefulness, respectively.[27] The tim-
ing of different phases of the cell cycle may vary in differ-
ent tissues, as it is set by different peripheral clocks. For
example, the highest levels of DNA synthesis in bone
marrow progenitors in healthy subjects were found to be
around noon and in the afternoon [28], whereas cells from
human colonic mucosa typically enter the G1 phase of the
cell cycle in late afternoon/early evening (around 6 pm)
and the S phase later in the night.[29]
The establishment of the circadian rhythm in the
developing embryo occurs relatively early in
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development, but only after the onset of differentiation in
the populations of progenitor cells (presumably, because
clock-regulated genes may significantly vary in different
tissues and the specificities of the diurnal rhythm may be
different in different cell types). At present, the prolifera-
tion of embryonic stem cells (ESC) maintained in the
undifferentiated (pluripotent) state is thought not to be
controlled by circadian mechanisms.[30,31] Only after
the cell is allowed to differentiate, the typical pattern
eventually surfaces. Nevertheless, some of the accessory
circadian rhythm proteins (e.g. Tim1) have been found to
play a role in developmental apoptosis, facilitating the
formation of early embryonic structures such as the
proamniotic cavity.[32] Most of the studies of the mainte-
nance of circadian rhythms in cultured cells, however,
have been carried out in rodent ESC. The latter may
exhibit properties that are very different from the properties
of ESC from other mammals and specifically from ESC
from primates and humans.[33] It is still unclear whether
cells of very early human embryos and cultured human
embryonic stem cells (hESC) are actually controlled by cir-
cadian rhythms.
The levels of expression of many proteins with roles in
carcinogenesis may be dependent (directly and/or indi-
rectly) on the circadian cycle. Some are, for example, prod-
ucts of known proto-oncogenes (e.g. the c-Myc family of
proteins); genes coding for proteins directly involved in the
transition through the major checkpoints of the cell cycle
(checkpoint kinases, cyclins and others); tumour-suppressor
genes (e.g. genes coding for CDK inhibitors  CDKN1A
(coding for the p21 (Waf1) protein and CDKN2A (coding
for p16 (INK)); genes coding for products functioning in
the maintenance of genomic integrity (Ataxia telangiectasia
mutated (ATM), p53, HMG of nonhistone proteins, etc.)
and genes encoding pro-apoptotic proteins and apoptosis
modulators (BCL-2 family  Bax, Puma and Gadd45).
Disruption of the circadian rhythm of cell division is con-
sidered important component in neoplastic transformation,
as DNA damage is a powerful signal for adjustment of the
circadian clock. The presence of DNA damage is usually
associated with cell cycle arrest for attempted repairs and/
or induction of apoptosis (if the damage is assessed as
irreparable). Repair activities are usually carried out prior
to the S-phase of the cell cycle to avoid transmission of
mutations to the progeny by replication of damaged DNA
templates. Of course, there are post-replication mechanisms
for induction of cell cycle arrest, but the G1/S checkpoint
is usually the most stringent cell cycle checkpoint. The
S-phase in eukaryotic cells is, as we mentioned above, usu-
ally carried out at night. The presence of DNA damage is
currently believed to constitute a specific cue for adjust-
ment of the circadian rhythm.[34] Presence of damage in
DNA usually brings about an advancement in the phase of
the circadian rhythm, as the damage must be repaired
before the cell could proceed with replication. The
mechanism of DNA damage-associated resetting of the
biological clock is conserved in all eukaryotes.[35] It
involves virtually all major signalling pathways associated
with presence of damage  the ATM/Ataxia telangiectasia
and Rad3-related protein (ATR) pathway and the p53-asso-
ciated pathways for induction of cell cycle arrest and/or
apoptosis but may also directly modulate the expression of
proteins functioning in cell cycle checkpoints  cyclins,
checkpoint kinases; factors stimulating cell proliferation
(e.g. c-Myc), and others.
Per2 mutant mice display a phenotype of accelerated
aging (progressive fur graying) after they have received a
non-lethal dose of ionizing radiation (an agent producing
double-strand breaks), similar to the Atm heterozygous
phenotype.[3638] This was interpreted as signal sug-
gesting that the functions of Per1 and Per2 proteins and
Atm converge to a common pathway.[36,38] Later, it was
shown that induced expression of Per1 in cancer cells
resulted in phosphorylation of Chk2 even in the absence
of DNA damage.[39] Per1 overexpression in human can-
cer cell lines inhibits tumour growth. In human cell lines
transfected with Per1, the proportion of cells in S-phase
decreased rapidly, while the proportion of cells in G2/M
phase increased.[39] Per1 and Per2 proteins are impli-
cated in the regulation of the ATM-Chk2/ATR-Chk1
DNA damage response pathways.[40] ATR and ATM are
serine/threonine kinases that function together as part of
the early response system after occurrence of DNA dam-
age, phosphorylating the Rad17 protein.[4144] ATM is
activated predominantly by double-strand breaks whereas
ATR may be activated by single-stranded DNA as well
(e.g. stalled replication forks). In response to DNA dam-
age, ATM phosphorylates the checkpoint kinase-2
(Chk2), whereas ATR phosphorylates checkpoint kinase-
1 (Chk1).[44] Catalytically active Chk2 acts upstream of
p53, stabilizing it by phosphorylation and eventually pro-
ducing cell cycle arrest in G1 in response to DNA dam-
age.[45,46] Chk1-mediated damage-associated pathways
typically cause cell cycle arrest in S and G2 phase.[46]
The accessory core clock protein Tim1 is essential for
ATR-dependent Chk1 activation and S-phase arrest.[47]
ATM/ATR-mediated damage signalling usually
results in S-phase advancements, with the magnitude of
the advancement dependent on the time of the day when
the damage occurred. In mouse cells treated with agents
causing double-strand breaks (activating ATM-associated
pathways), Per2 was degraded early after the occurrence
of DNA damage (early responder) and the next clock
phase was advanced, that is, it began earlier than normally
expected. The magnitude of the advancement was largest
in cases when DNA damage occurred at the time of de
novo synthesis of Per2 (during the day) and smallest at the
peak of Per2 (late in the night).[35] In the same study, UV
damage (associated with ATR-mediated response path-
way) was shown also to cause phase advancement in
178 K. Uth and R. Sleigh
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mouse cells, with magnitude of the advance dependent on
the timing of damage occurrence.
The tumour-suppressor protein p53 regulates, directly
or indirectly, between 2% and 4% of all genes in the mam-
malian genome.[48,49] p.53 is one of the downstream tar-
gets for phosphorylation by ATM in the DNA damage
response pathway. p53 phosphorylation by ATM causes
its stabilization and accumulation.[43,50,51] ATM also
phosphorylates the major negative regulator of p53
(MDM2), decreasing its capacity for exporting p53 from
the nucleus.[52,53] p53 may regulate directly the expres-
sion of Per2 via binding to a conserved response element
in its promoter.[54] The p53 response element in the Per2
gene partially overlaps with the E-box element responsi-
ble for the transcriptional activation of Per2 expression by
the Bmal1/Clock dimer. It was proposed that in the pres-
ence of damage, stabilized p53 blocks Bmal1/Clock from
binding to the Per2 promoter, leading to inhibition of the
expression of Per2 and advancement of the subjective day
phase.[54] Mouse models lacking p53 have a near-normal
circadian rhythm, but they exhibit shortening of the nor-
mal 24-h cycle and their biological clock may not be reset
correctly by light cues. In cultured cells with p53 knock-
out, the amplitude of the circadian rhythm is greatly
reduced.[55]
Stimulated overexpression of Bmal1 may inhibit
tumour growth. The activity of the Bmal1 promoter is
strongly enhanced upon DNA damage, but independently
of the moment in the subjective day the damage occurred.
[35] Bmal1 responds late (several hours) after damage has
occurred, activating the ATM-associated damage
response pathways.[35,38] Bmal1 stimulates the expres-
sion of p53, whereas the Cry proteins downregulate it.[56]
Cry proteins may play a role in the induction of apo-
ptosis by the p53-independent pathway. Mouse cells defi-
cient in both Cry proteins as well as p53 were much more
prone to apoptosis after genotoxic challenge than p53-
deficient cells that had functional copies of the Cry genes.
[55]
Treatment with genotoxic agents usually produces
oscillating elevations in the levels of pro-apoptotic pro-
teins. In cells of the same basic type, but with varying
levels of differentiation, the amplitude of circadian oscil-
lations of mRNA and protein associated with apoptotic
response may be different. A study carried out in mouse
haematopoietic cells from bone marrow showed that
treatment with ionizing radiation occurring at night
resulted in higher p21 and Mdm2 mRNA levels than the
levels produced by irradiation occurring during the day.
[57] At the same time, no significant differences in the
levels of the Bax or Puma were observed in cells from
bone marrow irradiated at different times of the day. In
cells isolated from peripheral blood, the amplitude of the
increase in the levels of p21, Mdm2, Bax and Puma after
irradiation occurring during the day were significantly
higher than the levels in nighttime irradiation.[57] The
level of the p53-regulated cell cycle inhibitor Gadd45a
oscillates in a circadian manner, with its expression
being directly regulated by Clock.[13,38]
c-Myc is one of the positive regulators of the cell
cycle that is directly controlled by the proteins of the
clock core complex. c-Myc is a cellular proto-oncogene, a
transcription factor, modulating (most commonly  acti-
vating, but also repressing) the expression of multiple
downstream genes directly implicated in cellular prolifer-
ation. The mouse c-Myc gene contains an E-box, where
the Clock/Bmal1 or the Clock/Npas2 complex normally
bind, inhibiting the transcription of the gene.[35] In Per2-
deficient mice, the levels of Bmal1/Npas2 or Bmal1/Clock
are reduced, which results in derepression of the expres-
sion of c-Myc.[36,38] Following gamma-irradiation, the
p53-mediated apoptosis mechanism in Per2-deficient
mice does not function adequately [36] and as a result, c-
Myc expression is not downregulated and the damaged
cells are capable of bypassing the cell cycle checkpoints
regardless of the presence of DNA damage, increasing the
risk for neoplastic transformation. Deregulation of the
expression of c-Myc is believed to constitute a major
pathogenetic mechanism in the establishment of the can-
cer-prone phenotype of Per2-mutant mice, and a risk fac-
tor for tumour growth in wildtype mice with disrupted
circadian cycle.[38,58] As the mechanisms of induction
of DNA repair and apoptosis are, however, partially
redundant, elevated levels of c-Myc may route the dam-
aged cells directly to apoptosis, without induction of cell
cycle arrest for attempted repair. This may be imple-
mented by c-Myc-mediated suppression of the expression
of the p21 (Waf1,Cip1), a CDK inhibitor inducible by sta-
bilized p53.[39] It is believed that Per1 overexpression
inhibits tumour growth by making damaged cells more
susceptible to apoptosis via induction of c-Myc/repression
of p21.[59] Dec1 and Dec2 proteins repress Clock/Bmal1-
induced transactivation of the Per1 promoter in the mouse
via direct interaction with Bmal1 as well as by competing
with Bmal1 for the E-box elements in the Per1 promoter.
[59]
Expression of cyclins also exhibits circadian rhythms.
The levels of expression of cyclins D1 and E reach their
highest level in early evening (6 pm), in preparation for
the G1/S transition; and their lowest level around mid-
night when the actual cell division is about to start.[29] In
the same study, the expression of the cyclin-dependent
kinase inhibitors p16 (INK4, or multiple tumour suppres-
sor 1 (MTS1)) and p21 exhibited their lowest levels
around noon and at 6 pm, respectively. The accessory cir-
cadian factor Dec1 is known to bind directly to cyclin D1
to a designated Dec response element, inhibiting its
expression.[20,60] The levels of cyclin B1, and its pairing
partner cdc2 (CDK1), chiefly responsible for the transition
from G2 to M phase of the cell cycle, and cyclin A2
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(functioning in the S and G2 phases) have been found to
be deregulated in Cry-deficient mouse models.[61] In
Cry-deficient mice with partial hepatectomy, the expres-
sion peaks of cyclin B1, cdc2, Bub1 (a serine/threonine
kinase essential for the correct chromosome alignment in
mitosis), cyclin A2 and the cyclin A2-associated protein
p55CDC occurred 812 hours later than those in wild-
type mice, which resulted in impaired liver regeneration.
[61] The expression of Wee1, a negative regulator of the
activity of cyclin B/cdc2 complex is directly regulated in
a circadian fashion, being activated by the Bmal1/clock
heterodimer and inactivated by the Per/Cry complex.[61]
Overexpression of Per1 in mouse cells downregulates the
expression of cyclin B and cdc2, contributing to the anti-
tumour effect of Per1.[39] The interaction, however, is
not direct, rather, it is likely to be p53-mediated, as down-
regulation was observed only in p53-expressing/Per1
overexpressing cells and not in p53-deficient/Per1 overex-
pressing cells.[39,61]
Several of the proteins functioning directly in the rec-
ognition and repair of DNA damage are expressed in a cir-
cadian fashion.[6264] The levels of the mRNA and
protein of the nucleotide excision repair (NER) factor
XPA have been found to oscillate within the 24-h cycle,
with 510-fold changes in amplitude between the lowest
and the highest levels; and in anti-phase with the levels of
the negative core loop regulator Cry1.[62] The XPA gene
is believed to be controlled directly by the circadian clock,
as its promoter contains E-box elements.[65] In double-
mutant Cry1-/Cry2-deficient mice, the levels of Xpa were
constitutively high.[65] The levels of other proteins of
DNA repair enzymes  specifically, alkylguanine DNA
glycosylase (an enzyme of base excision repair (BER))
and O6-methylguanine-DNA-methyltransferase (function-
ing in direct repair) also tend to oscillate within the 24-h
cycle, but the amplitude between the highest and the low-
est levels in the cycle is significantly lower than the levels
seen with Xpa.[66,67] This may be related to the fact
that the enzymatic machinery of NER is engaged for
repair of virtually all types of lesions, apart from base mis-
matches and double-strand breaks, whereas enzymes of
BER and direct repair usually operate on specific sub-
strates only.
In terminally differentiated cells, the repair of damage
occurring in non-transcribed regions of the genome is
much less efficient than in transcribed regions.[68] This is
presumably associated with the fact that differentiated
cells practically never divide; therefore, it is highly
unlikely mutations would be transmitted to the cell’s
progeny.[69] At present, it is unclear whether occurrence
of damage in the non-transcribed regions in differentiated
cells (where presumably the presence of damage is selec-
tively ignored) would reset the circadian clock as effi-
ciently as damage occurring in the transcribed regions of
the genome.
It is now believed that chromatin remodelling is essen-
tial for the correct functioning of the circadian clock, as
the core feedback loop regulation includes chromatin
modifications. The Clock-Bmal1 complex (specifically,
Clock) possesses histone acetyltransferase activity, the
preferred target for acetylation being the Lys14 residue of
nucleosomal histone H3.[70,71] Acetylation of Lys14 has
been associated with ‘opening’ of the local chromatin
structure.[72] As with most histone acetyltransferases,
Clock may also acetylate nonhistone substrate proteins,
including its pairing partner Bmal1.[70,73] The acetyla-
tion of Bmal1 is carried out on a specific conserved Lys
residue (Lys537) and serves as a signal for recruitment of
the negative regulator protein Cry1. Bmal1 is acetylated
by Clock in a rhythmic manner within the 24-h cycle in
the mouse, with the timing of acetylation coinciding with
the down-regulation of the transcription of the genes
directly controlled by the circadian clock.[70] HMG pro-
teins are a diverse group of non-histone proteins function-
ing in the supramolecular organization of chromatin and
chromatin remodelling.[74,75] HMGB1 functions in vir-
tually all types of DNA repair, facilitating the recognition
of the lesion and signalling for recruitment of the DNA
repair machinery.[7678], but may also inhibit DNA
repair.[77,79] HMG proteins are normally present at low
levels in adult somatic cells.[8082], but their levels may
vary within the 24-h cycle. The levels of Hmgb1 protein
oscillates in rat retinal photoreceptor cells, with the
expression peaking at the middle of the subjective day
and reaching its lowest level at night.[83] Within the
nucleus of the photoreceptor cell in the mouse, Hmgb1
co-localizes with acetylated histone H3 (a direct substrate
of Clock).[70,83] The circadian changes in the levels of
Hmgb1 may therefore reflect the rhythmic changes in
chromatin conformation associated with DNA replication
and repair. Overexpression of HMGA may suppress DNA
repair and directly inhibit the expression of some clock-
regulated proteins directly involved in DNA repair, such
as XPA.[84,85] The presence of variant alleles of the
Hmga1 gene in mice and humans was shown to be associ-
ated with severe early-onset insulin resistance and diabe-
tes type 2.[86,87] The expression of Hmga1 is up-
regulated in the majority of cancers.[78,8890] It has
been proposed that HMG deregulation may increase the
risk for neoplastic growth [91,92], but the exact mecha-
nism/s are currently unknown. The role of deregulated cir-
cadian rhythm of chromatin remodelling, however, cannot
be excluded.
Conclusions
The mechanisms ensuring the rhythmic oscillation of core
clock proteins and clock-regulated proteins are tightly
linked and reset by the signalling molecules and pathways
involved in DNA damage recognition, damage-associated
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signalling, DNA repair and apoptosis pathways. The
dynamics of the chromatin structure are also regulated in
a circadian pattern, allowing for the precise timing of
DNA transactions within the 24-h cycle. Deregulation of
the normal circadian rhythm (e.g. bedtime misalignment,
chronic jet lag, etc.) may increase the risk for develop-
ment of multifactorial disease (best studied in cancer, but
experimental proof exists also for metabolic syndrome/
diabetes type 2, cardiovascular and neurological disease);
may accelerate cancer progression and/or modify the out-
comes for cancer patients.
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